AnalystsFaisal KhurshidFaisal Khurshid's Stock Forecasts
AnalystsFaisal Khurshid
Sectors:
Analyst Ranking
Top 23%
#1171 out of 5116 analysts
Average Return
+17.12%
Win Rate
50%11 out of 22
Risk vs Reward
Poor
Good
Faisal Khurshid's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Spyre Therapeutics IncSYRE | +154.24% | $11.80 | $30.00 | 2025-04-08 - 2025-11-28 | Buy |
Shattuck Labs IncSTTK | +144.19% | $0.86 | $2.10 | 2025-08-14 - 2025-11-28 | Buy |
Trevi Therapeutics IncTRVI | +143.59% | $3.12 | $7.60 | 2024-09-09 - 2025-09-08 | Buy |
Shattuck Labs IncSTTK | +79.49% | $1.17 | $2.10 | 2025-03-17 - 2025-11-28 | Buy |
Kymera Therapeutics IncKYMR | +69.23% | $40.11 | $67.88 | 2024-12-27 - 2025-11-28 | Buy |
Faisal Khurshid Analyst Color
Get additional color on Faisal Khurshid's coverage of popular stocks
Faisal Khurshid's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Trevi Therapeutics IncTRVI | 2 | Buy | $16.00 | +21.30% | Maintains | 12 days ago |
Abcellera Biologics IncABCL | 2 | Hold | $4.00 | +7.24% | Downgrades | 25 days ago |
Galapagos NvGLPG | 2 | Buy | $40.00 | +27.71% | Upgrades | a month ago |
Contineum Therapeutics IncCTNM | 1 | Buy | $20.00 | +80.67% | Initiates Coverage On | 2 months ago |
Protagonist Therapeutics IncPTGX | 1 | Buy | $73.00 | -18.89% | Initiates Coverage On | 3 months ago |
Shattuck Labs IncSTTK | 2 | Buy | $2.00 | -4.76% | Maintains | 4 months ago |
Rhythm Pharmaceuticals IncRYTM | 2 | Buy | $102.00 | -6.50% | Maintains | 5 months ago |
Ironwood Pharmaceuticals IncIRWD | 2 | Hold | $1.00 | -71.43% | Maintains | 8 months ago |
Spyre Therapeutics IncSYRE | 1 | Buy | $45.00 | +50.00% | Initiates Coverage On | 8 months ago |
Nurix Therapeutics IncNRIX | 1 | Hold | $16.00 | -9.50% | Initiates Coverage On | 8 months ago |
Pliant Therapeutics IncPLRX | 2 | Hold | $2.00 | +24.22% | Downgrades | 9 months ago |
Atyr Pharma IncATYR | 1 | Buy | $16.00 | +1,948.66% | Initiates Coverage On | 9 months ago |
Kymera Therapeutics IncKYMR | 2 | Buy | $60.00 | -11.61% | Maintains | a year ago |
Ani Pharmaceuticals IncANIP | 1 | Buy | $80.00 | -5.72% | Initiates Coverage On | a year ago |
Zura Bio LtdZURA | 1 | Buy | $15.00 | N/A | Initiates Coverage On | a year ago |
Puretech Health PLCPRTC | 1 | Buy | $45.00 | N/A | Assumes | a year ago |
Geron CorpGERN | 1 | Buy | $7.00 | N/A | Initiates Coverage On | a year ago |
Mannkind CorpMNKD | 1 | Buy | $8.00 | N/A | Assumes | a year ago |
Immunic IncIMUX | 1 | Buy | $5.00 | N/A | Assumes | a year ago |
Fusion Pharmaceuticals IncFUSN | 1 | Hold | $21.00 | N/A | Downgrades | 2 years ago |
Rain Oncology IncRAIN2 | 1 | Buy | $11.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.